Skip to main content
Clinical Trials/NCT03785535
NCT03785535
Completed
N/A

Functional MRI Study of the Effects of Vibrotactile Sensory Stimulation on Brain Activity in Fibromyalgia Patients

Neurovoxel SLP1 site in 1 country60 target enrollmentJanuary 15, 2019
ConditionsFibromyalgia

Overview

Phase
N/A
Intervention
Not specified
Conditions
Fibromyalgia
Sponsor
Neurovoxel SLP
Enrollment
60
Locations
1
Primary Endpoint
Functional MRI measures of brain functional connectivity. A correlation scale ranging from 0 to 1 will be used.
Status
Completed
Last Updated
5 years ago

Overview

Brief Summary

The purpose of this study is to investigate the effects of low-intensity and prolonged vibrotactile sensory stimulation on brain activity and functional connectivity in fibromyalgia patients.

Registry
clinicaltrials.gov
Start Date
January 15, 2019
End Date
February 28, 2021
Last Updated
5 years ago
Study Type
Interventional
Study Design
Parallel
Sex
Female

Investigators

Sponsor
Neurovoxel SLP
Responsible Party
Principal Investigator
Principal Investigator

Jesus Pujol

Principal Investigator

Neurovoxel SLP

Eligibility Criteria

Inclusion Criteria

  • A diagnosis of fibromyalgia according to the American College of Rheumatology (ACR) (Arthritis Care Res 2010;62:600-10).
  • Clinical symptoms are not a consequence of other medical disorder (although the presence of other disorders is not an exclusion criterion)
  • Diagnoses established by an expert on fibromyalgia.
  • Stable treatment of chronic use.
  • Subject demonstrates an understanding of the study and a willingness to participate as evidenced by voluntary written informed consent.

Exclusion Criteria

  • Generalized inflammatory articular or rheumatic disease.
  • Severe, non-stable medical, endocrinological or neurological disorder.
  • Psychotic disorder or drug abuse.

Outcomes

Primary Outcomes

Functional MRI measures of brain functional connectivity. A correlation scale ranging from 0 to 1 will be used.

Time Frame: 3 weeks

Change on brain activity rated using functional MRI measures of functional connectivity

Functional MRI measures of brain activity. A functional MRI signal change scale ranging from 0 to 1 will be used.

Time Frame: 3 weeks

Change on brain activity rated using functional MRI measures of brain activation in response to nociceptive stimulation

Secondary Outcomes

  • Tolerability rated using a numerical rating scale ranging from 0 to 100 points.(3 weeks)
  • Functional MRI measures of sensory system activity. A functional MRI signal change scale ranging from 0 to 1 will be used.(3 weeks)
  • Measured fibromyalgia symptoms using a 101-point numerical rating scale.(3 weeks)

Study Sites (1)

Loading locations...

Similar Trials